AstraZeneca SWOT Analysis Sample UK

Parent Company: AstraZeneca Biopharmaceuticals

Category: Pharmaceutical

Sector: Pharma and Healthcare

Tagline/ Slogan: Health connects us all

USP: AstraZeneca is a global, innovation-driven, integrated biopharmaceutical company.

Founded in: AstraZeneca was created through the merger of Astra AB and Zeneca Group plc in 1999.

Competition: GlaxoSmithKline, Merck & Co., Inc., Johnson & Johnson, Hoffman-La Roche

AstraZeneca is a global, innovation-driven, integrated biopharmaceutical company. The company has a broad portfolio of products for major disease areas including cancer, cardiovascular, gastrointestinal, infectious disease, neuroscience, respiratory and inflammation. AstraZeneca was created through the merger of Astra AB and Zeneca Group plc in 1999. The company has its headquarters in London, United Kingdom.

AstraZeneca is a global leader in the pharmaceutical industry. The company’s products are sold in over 100 countries around the world. AstraZeneca has a strong presence in Europe, North America and Asia Pacific. The company’s product portfolio includes drugs for various therapeutic areas such as cancer, cardiovascular, gastrointestinal, infectious disease, neuroscience and respiratory. AstraZeneca has a strong research and development pipeline with over 60 molecules in clinical development. AstraZeneca marketing creating customer value. The AstraZeneca strategy analysis is built on the pillars of innovation, access and patient experience. 

Let’s take a look at the company’s strengths, weaknesses, opportunities and threats.

AstraZeneca Strengths:

1. Strong product portfolio with blockbuster drugs – AstraZeneca has a strong product portfolio with several blockbuster drugs. The company’s top-selling products include Crestor, Nexium, Seroquel and Symbicort. These products have helped the company to generate strong revenue growth in recent years.
2. Strong presence in key markets – AstraZeneca has a strong presence in key markets such as Europe, North America and Asia Pacific. The company’s products are sold in over 100 countries around the world.
3. Strong research and development pipeline – AstraZeneca has a strong research and development pipeline with over 60 molecules in clinical development. The company is focused on developing new treatments for cancer, cardiovascular, neuroscience and respiratory diseases.
4. Strong financial position – AstraZeneca has competitive advantage of having a strong financial position with reported revenues of $25.9 billion in 2016. The company’s operating margin was 21.3% in 2016.
5. Experienced management team – AstraZeneca is led by an experienced management team with a proven track record in the pharmaceutical industry.

AstraZeneca Weaknesses

1. Dependence on blockbuster drugs – AstraZeneca is heavily dependent on its blockbuster drugs for revenue growth. The loss of patent protection for these drugs will impact the company’s revenue and profitability in the future.
2. Stringent regulation – The pharmaceutical industry is subject to stringent regulation. AstraZeneca must comply with strict regulations in order to sell its products in markets around the world.
3. High cost of research and development – AstraZeneca spends a significant amount on research and development each year. The high cost of research and development can impact the company’s profitability.
4. Pricing pressure – AstraZeneca faces pricing pressure from payers and government organizations around the world. The company must manage its prices carefully in order to maintain strong revenue growth.
5. Competition – AstraZeneca competes with large pharmaceutical companies such as GlaxoSmithKline, Merck & Co., Inc., Johnson & Johnson and Hoffman-La Roche.

Opportunities

1. Emerging markets – AstraZeneca has a strong presence in emerging markets such as China and India. The company’s products are well-positioned to benefit from the growing demand for healthcare in these markets.
2. New product launches – AstraZeneca has several new products in its pipeline that are expected to be launched in the next few years. These products have the potential to generate strong revenue growth for the company.
3. Strategic partnerships – AstraZeneca has entered into strategic partnerships with other companies in order to jointly develop and commercialize new products. These partnerships will help the company to reduce its research and development costs.
4. Acquisitions – AstraZeneca has made several acquisitions in recent years. These acquisitions have helped the company to expand its product portfolio and geographic reach.
5. Product licensing – AstraZeneca licenses its products to other companies for commercialization. This provides the company with an additional revenue stream.

Threats

1. Patent expiration – AstraZeneca’s top-selling drugs are facing the risk of patent expiration in the next few years. The loss of patent protection will allow generic companies to enter the market and sell cheaper versions of these drugs.
2. Regulatory changes – AstraZeneca’s products are subject to stringent regulation. Changes in regulations could impact the company’s ability to sell its products in certain markets.
3. Competition from generic drugs – AstraZeneca faces competition from generic drugs in the market. Generic drugs are typically cheaper than branded drugs and this could impact the company’s revenue growth.
4. Economic conditions – AstraZeneca’s performance is impacted by economic conditions around the world. A slowdown in the global economy could lead to lower demand for the company’s products.
5. Geopolitical risk – AstraZeneca’s operations are located in several countries around the world. The company is exposed to geopolitical risk, which could impact its business.

Buy Affordable Help With SWOT Analysis of AstraZeneca From Experienced UK Writers

Get assignment writing help in UK with the SWOT analysis of AstraZeneca from skilled and experienced writers! Students Assignment Help is here to help you out from this problem. Our writers have years of experience in this field and know all about the requirements that your professors might ask for in such assignments.

Ask our experts to “do my assignment”  and get it completed before the deadline. Our writers can provide you with research paper writing services,  case study writing, and essay help on any AstraZeneca topics of your choice.

Students can easily buy AstraZeneca stock analysis from StudentsAssignment Help.co.uk at the pocket-friendly price. So without wasting any further time place your order with us now to get high grades in your next AstraZeneca company analysis assignment.